Crossmark

Real life experience of tafamidis for the treatment of Spanish patients with Val30Met transthyretin amyloidosis with polyneuropathy

Crossref DOI link: https://doi.org/10.1016/j.medcle.2024.01.006

Published Print: 2024-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sanso, Maria Antonia Ribot

Rodriguez, Adrián Rodriguez

Vicente, Laura Martínez

Sevilla, Teresa

Garro, Cristina Borrachero

Martín, Julian Fernández

Vicente, Adrián Antón

de la Prida, Moises Morales

Dávila, Lucía Galán

Vázquez, Laura González

Valle, Ferran Martínez

Pons, Carlos Casasnovas

Bau, Arturo Fraga

Barroso, Eugenia Cisneros

López, Inés Losada

González-Moreno, Juan
License Information

Text and Data Mining valid from 2024-05-01

Text and Data Mining valid from 2024-05-01

stm-asf valid from 2024-05-01

stm-asf valid from 2024-05-01

stm-asf valid from 2024-05-01

stm-asf valid from 2024-05-01

stm-asf valid from 2024-05-01
More Information

This article is maintained by: Elsevier

Article Title: Real life experience of tafamidis for the treatment of Spanish patients with Val30Met transthyretin amyloidosis with polyneuropathy

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2024.01.006

Content Type: article

Copyright: © 2024 Elsevier España, S.L.U. All rights reserved.